Article Text

Download PDFPDF
Post lung-transplant recipients with worsening depression: the need to identify, refer, and treat, but does it really help?
  1. Sarah Andrews
  1. Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA
  1. Correspondence to Dr Sarah Andrews, Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA; sarah.andrews{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

All lung transplant patients must undergo a psychosocial evaluation during the transplant process, which is vital in appreciating patients’ strengths, as well as any potential risk factors. Screening for psychiatric disorders is not used as an absolute exclusion measure, but rather a means to identify and better manage patients who may benefit from additional resources during the pretransplant and post-transplant periods.1 2

Depression, a treatable condition, can range from mild to severe with different interventions available.3 Given that the transplant process can be stressful for patients, screening for depression and subsequently treating even mild depression is vital for transplant patients. Screening must occur not only pretransplant, but also …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles